Marlborough

Marlborough’s Sprout, a cloud-based customer relationship management and marketing platform for the cannabis industry, has partnered with an e-commerce solution for cannabis dispensaries.

Marlborough diagnostics company Oxford Immunotec, which is also headquartered in the United Kingdom, has teamed up with Public Health England, an executive agency of the UK’s Department for Health and Social Care, to conduct research around at-home COVID-19 tests.

Marlborough’s Dalbar Inc., an independent auditor of financial institutions, has released a new study in which it reportedly found gaps in the ways banks approach COVID-19 safety.

Marlborough medical technology device company Hologic plans to launch a nearly $1-billion private offering to refinance existing unsecured notes due in 2025, the company announced on Monday.

Medical technology company Hologic, headquartered in Marlborough, announced Wednesday it has acquired Acessa Health Inc. for approximately $80 million in cash plus contingent payments based on future revenue growth.

A U.S. Court of Appeals for the First Circuit has dismissed a 2017 class action lawsuit filed against ReWalk Robotics of Marlborough on Tuesday, according to a press release from the medical device manufacturer. 

Founded while CEO Tom Galati was still in college, the company, which has offices in Maryland, works with clients to help bring their drugs and therapeutics to the marketplace through pre-clinical and clinical research.

Diagnoses of six major types of cancer dropped 46% in the early weeks of the pandemic, according to a study published in the Journal of the American Medical Association using Quest Diagnostics data.

Marlborough company Block MEMS has received a $1.7 million contract from the U.S. Department of Homeland Security Countering Weapons of Mass Destruction for a system to detect  trace quantities of drugs and chemicals in parcels in the United States.

StageBio, a company with locations in Virginia and Maryland, has expanded into the Massachusetts market with a new, 10-person facility in Marlborough.